Lena Jendeberg
Modus Therapeutics (Sweden)(SE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Peroxisome Proliferator-Activated Receptors, Antimicrobial Resistance in Staphylococcus, Pharmacogenetics and Drug Metabolism, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction(1998)868 cited
- → Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ(1998)255 cited
- → High-level production of uniformly 15N-and 13C-enriched fusion proteins in Escherichia coli(1996)186 cited
- → Kinetic analysis of the interaction between protein a domain variants and human Fc using plasmon resonance detection(1995)95 cited
- → The Mechanism of Binding Staphylococcal Protein A to Immunoglobin G Does Not Involve Helix Unwinding†(1996)85 cited
- → A New Class of Peroxisome Proliferator-activated Receptor Agonists with a Novel Binding Epitope Shows Antidiabetic Effects(2004)80 cited
- → The serum albumin‐binding domain of streptococcal protein G is a three‐helical bundle: a heteronuclear NMR study(1996)73 cited
- → Engineering of Fc1 and Fc3 from human immunoglobulin G to analyse subclass specificity for staphylococcal protein A(1997)69 cited
- → Identification of residues in the PXR ligand binding domain critical for species specific and constitutive activation(2002)42 cited
- → A Triple Mutant of the Drosophila ERR Confers Ligand-Induced Suppression of Activity(2003)30 cited